HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 43 filers reported holding HARPOON THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $53,000 | -41.1% | 10,723 | -10.0% | 0.00% | – |
| Q4 2021 | $90,000 | +1.1% | 11,921 | +5.2% | 0.00% | – |
| Q3 2021 | $89,000 | -64.5% | 11,329 | -37.4% | 0.00% | – |
| Q2 2021 | $251,000 | -22.8% | 18,102 | +16.5% | 0.00% | – |
| Q1 2021 | $325,000 | +34.9% | 15,535 | +7.2% | 0.00% | – |
| Q4 2020 | $241,000 | +138.6% | 14,494 | +144.0% | 0.00% | – |
| Q3 2020 | $101,000 | +12.2% | 5,940 | +9.3% | 0.00% | – |
| Q2 2020 | $90,000 | +246.2% | 5,436 | +136.7% | 0.00% | – |
| Q1 2020 | $26,000 | -54.4% | 2,297 | -41.9% | 0.00% | – |
| Q4 2019 | $57,000 | +111.1% | 3,955 | +91.0% | 0.00% | – |
| Q3 2019 | $27,000 | -53.4% | 2,071 | -54.9% | 0.00% | – |
| Q2 2019 | $58,000 | +107.1% | 4,591 | +45.2% | 0.00% | – |
| Q1 2019 | $28,000 | – | 3,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $24,938,000 | 7.19% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $24,738,000 | 5.73% |
| MPM BioImpact LLC | 3,196,707 | $25,254,000 | 3.92% |
| Affinity Asset Advisors, LLC | 250,000 | $1,975,000 | 0.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 215,000 | $1,696,000 | 0.41% |
| Orbimed Advisors | 2,611,308 | $20,629,000 | 0.23% |
| DAFNA Capital Management LLC | 105,163 | $831,000 | 0.22% |
| Avidity Partners Management LP | 1,190,600 | $9,406,000 | 0.21% |
| Artal Group S.A. | 1,000,000 | $7,900,000 | 0.18% |
| Cormorant Asset Management, LP | 540,600 | $4,271,000 | 0.17% |